(PINC) Premier - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74051N1028
PINC: Medical Supplies, Pharmaceuticals, Laboratory Equipment, Food Products
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company that operates at the intersection of supply chain optimization and performance services. Headquartered in Charlotte, North Carolina, Premier serves as a critical partner to healthcare providers across the U.S., helping them reduce costs, improve efficiency, and enhance patient outcomes. The company’s dual-segment business model—Supply Chain Services and Performance Services—positions it as a comprehensive solution provider in the healthcare industry.
The Supply Chain Services segment is the backbone of Premier’s operations, offering a vast portfolio of products and services tailored to meet the diverse needs of healthcare providers. This includes medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, and food and nutritional products. Beyond physical goods, the segment also provides purchased services such as clinical engineering and workforce solutions. Premier’s ASCENDrive programs, for instance, enable members to leverage group purchasing power to secure better pricing tiers and standardized contracts. The SURPASS Performance Group takes this a step further by coordinating purchasing decisions and ensuring utilization efficiency across member facilities. Additionally, the segment offers SaaS informatics products, supply chain co-management services, direct sourcing solutions, and supply chain resiliency programs, all designed to create a more sustainable and adaptive supply chain ecosystem.
Complementing its supply chain offerings, Premier’s Performance Services segment delivers a technology and services platform aimed at optimizing clinical, financial, and operational performance. Under the PINC AI brand, the company provides advanced clinical intelligence and margin improvement tools, enabling healthcare providers to make data-driven decisions. The Contigo Health brand focuses on third-party administration and management of health benefit programs, while the Remitra brand offers digital invoicing and payables services, streamlining financial operations for healthcare suppliers and providers. This segment underscores Premier’s commitment to driving value-based care and financial sustainability in the healthcare sector.
From a financial perspective, Premier Inc. is well-positioned as a mid-cap company with a market capitalization of $1.93 billion. The stock currently trades at a P/E ratio of 44.43, reflecting expectations of strong future growth, with a forward P/E of 15.77 suggesting a more normalized valuation outlook. The price-to-book ratio of 0.94 indicates that the stock is trading near its book value, which may present an attractive entry point for value investors. The price-to-sales ratio of 1.50, meanwhile, highlights the company’s revenue generation capabilities relative to its market valuation.
Investors and fund managers should consider Premier’s role as a major player in the healthcare cost reduction and efficiency space. The company’s diversified revenue streams, extensive product and service offerings, and strategic positioning in a sector undergoing significant transformation make it a compelling candidate for portfolios focused on healthcare innovation and long-term growth.
Additional Sources for PINC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PINC Stock Overview
Market Cap in USD | 1,931m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2013-09-26 |
PINC Stock Ratings
Growth 5y | -42.2% |
Fundamental | 6.01% |
Dividend | 68.0% |
Rel. Strength Industry | -11.1 |
Analysts | 2.88/5 |
Fair Price Momentum | 16.56 USD |
Fair Price DCF | 93.26 USD |
PINC Dividends
Dividend Yield 12m | 3.34% |
Yield on Cost 5y | 2.21% |
Annual Growth 5y | 17.19% |
Payout Consistency | 99.2% |
PINC Growth Ratios
Growth Correlation 3m | -67.8% |
Growth Correlation 12m | 14.1% |
Growth Correlation 5y | -62.4% |
CAGR 5y | -8.61% |
CAGR/Max DD 5y | -0.16 |
Sharpe Ratio 12m | -0.75 |
Alpha | -16.67 |
Beta | 0.34 |
Volatility | 22.67% |
Current Volume | 1348k |
Average Volume 20d | 1371.3k |
As of March 15, 2025, the stock is trading at USD 18.16 with a total of 1,347,985 shares traded.
Over the past week, the price has changed by -0.27%, over one month by +3.40%, over three months by -15.56% and over the past year by -10.28%.
Neither. Based on ValueRay Fundamental Analyses, Premier is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 6.01 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PINC as of March 2025 is 16.56. This means that PINC is currently overvalued and has a potential downside of -8.81%.
Premier has received a consensus analysts rating of 2.88. Therefor, it is recommend to hold PINC.
- Strong Buy: 0
- Buy: 0
- Hold: 7
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, PINC Premier will be worth about 18 in March 2026. The stock is currently trading at 18.16. This means that the stock has a potential downside of -1.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.8 | 9% |
Analysts Target Price | 20.9 | 14.9% |
ValueRay Target Price | 18 | -1.1% |